Global Immunoadsorption Columns Market Growth (Status and Outlook) 2025-2031

The global Immunoadsorption Columns market size is predicted to grow from US$ 31.7 million in 2025 to US$ 49.9 million in 2031; it is expected to grow at a CAGR of 7.9% from 2025 to 2031.

Immunoadsorption columns have been widely employed for the purification of specific antibodies and antigens. In immunoadsorption columns, plasma is removed by apheresis and passed on through an adsorption medium to remove harmful antibodies, following which it is re-infused into the patient.

Immunoadsorption columns are increasingly being recognised as a promising and low-risk therapy option in a variety of cardiac, haematological, neurological and various other disorders. Immunoadsorption columns are also being increasingly recognised as a useful therapeutic option for various chronic and acute disorders such as multiple sclerosis, Guillain-Barre, myasthenia gravis, chronic inflammatory demyelinating polyneuropathy and autoimmune encephalitis. Using immunoadsorption columns, plasma components are separated by adsorber systems that are designed to selectively bind immunoglobulins. The preservation of plasma proteins, such as coagulation factors, albumin and lower shift of blood volumes, during a procedure is one of the advantages of immunoadsorption columns over other conventional techniques such as plasma exchange.

Various different adsorbers, such as tryptophan, protein A or polyclonal sheep antibodies, can be used alone with immunoadsorption columns. Immunoadsorption columns with protein A or sheep antibodies enable more selective removal of immunoglobulins as well as regenerating mechanisms. Most of the modern immunoadsorption columns contain 2 columns that undergo alternating loading and regeneration cycles, which assists in saving time for even larger blood volumes to be processed.

Global immunoadsorption column includes Asahi Kasei, Fresenius Medical Care Adsorber, etc. Global top 3 companies hold a share about 80%. North America is the largest market, with a share about 40%, followed by Europe and Asia-Pacific with the share about 30% respectively. In terms of product, single-use is the largest segment, with a share over 70%. And in terms of application, the largest application is hospital, with a share about 80%.

LPI (LP Information)' newest research report, the “Immunoadsorption Columns Industry Forecast” looks at past sales and reviews total world Immunoadsorption Columns sales in 2024, providing a comprehensive analysis by region and market sector of projected Immunoadsorption Columns sales for 2025 through 2031. With Immunoadsorption Columns sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Immunoadsorption Columns industry.

This Insight Report provides a comprehensive analysis of the global Immunoadsorption Columns landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Immunoadsorption Columns portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Immunoadsorption Columns market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Immunoadsorption Columns and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Immunoadsorption Columns.

This report presents a comprehensive overview, market shares, and growth opportunities of Immunoadsorption Columns market by product type, application, key players and key regions and countries.

Segmentation by Type:
Single Use Immunoadsorption Columns
Reuse Immunoadsorption Columns

Segmentation by Application:
Hospitals
Specialty Clinics
Academic & Research Centres
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Fresenius Medical Care Adsorber Tec
Asahi Kasei
Miltenyi Biotec
POCARD Ltd
Jafron Biomedical
Guangzhou Kangsheng Biotechnology

Please note: The report will take approximately 2 business days to prepare and deliver.